Sign in to continue:

Tuesday, January 27th, 2026

Civmec Limited Announces Tax Exempt (Foreign Sourced) Interim Dividend for FY2025

Title: Civmec Limited Announces Interim Dividend – A Potential Boost for Shareholders
Civmec Limited, a leading construction and engineering services provider, has recently announced the details of its proposed tax-exempt (Foreign Sourced) interim dividend for the financial year ending 30 June 2025. This news is likely to be of significant interest to the company’s shareholders and may have a potential impact on the share price.
Key Highlights:
Civmec Limited will be closing its Register of Members and Share Transfer Books on 27 March 2025 for the preparation of the interim dividend warrants. 1
The proposed interim dividend is set at $A0.025 per share. 1
Shareholders whose securities accounts with The Central Depository (Pte) Limited are credited with Civmec shares as of 5:00 p.m. on 26 March 2025 (the “Record Date”) will be entitled to receive the interim dividend. 1
The interim dividend is scheduled to be paid on 11 April 2025. 1
Potential Impact on Share Price: The announcement of the interim dividend is likely to be viewed positively by Civmec’s shareholders, as it suggests the company’s financial performance and cash flow position are strong enough to support a dividend payout. This could potentially lead to an increase in investor demand for the company’s shares, potentially driving up the share price.
Moreover, the timing of the dividend payout, which is scheduled for April 2025, may also be seen as favorable, as it could provide a timely boost to shareholders’ returns.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. The information provided in this article is based on publicly available information and may be subject to change. The author and the publication cannot guarantee the accuracy or completeness of the information presented.

View Civmec Historical chart here



iX Biopharma Recognised as One of Singapore’s Fastest Growing Companies 2026 for Third Time, Driven by WaferiX Drug Delivery Platform and US Expansion 1

iX Biopharma Ltd. (SGX-listed specialty pharmaceutical company, Co. Reg. No: 200405621W) has announced its inclusion in The Straits Times’ Singapore’s Fastest Growing Companies 2026 ranking, compiled in partnership with global research firm Statista. This...

Yangzijiang Financial Holding Ltd. Announces Record Date and Dividend Payment Date for Proposed Final Dividend

Title: Yangzijiang Financial Holding Ltd. Announces Proposed Final Dividend for FY2024 – A Potential Boon for Shareholders Key Highlights: Yangzijiang Financial Holding Ltd. (the “Company”) has proposed a tax-exempt (one-tier) final dividend of S$0.0345...

CapitaLand Investment Expands Asia Pacific Logistics Portfolio with S$260 Million Automated Facility in Singapore and Strategic ALP Partnership

Key Highlights CapitaLand Investment Limited (CLI) announces two major initiatives to deepen logistics expertise and accelerate growth across Asia Pacific. Minority investment in Ally Logistic Property (ALP) – a pioneer in smart logistics infrastructure...